An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09).

  • Ahn, Myung-Ju; 
  • Cho, Jang Ho; 
  • Sun, Jong-Mu; 
  • Lee, Se-Hoon; 
  • Ahn, Jin Seok; 
  • ... Kang, Eun Joo; 
  • 외 5명
제목
An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09).
저자
Ahn, Myung-Ju; Cho, Jang Ho; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Kang, Eun Joo; Choi, Yoon Hee; Kim, Ki Hwan; An, Ho Jung; Lee, Hyun Woo
DOI
10.1200/JCO.2018.36.15_suppl.9050
발행일
2018-05-20
학회명
2018 ASCO Annual Meeting
개최지
Chicago, Illinois, USA
개최국가
미국
학회 개최일
2018-06-01 ~ 2018-06-05